Cosmos Health Announces Testing Completion Of C-Scrub Wash 4% Under European Standard For Surgical Hand Disinfection Shows Effective Antimicrobial Activity
4/1/2026
Impact: 75
Healthcare
Cosmos Health Inc. (NASDAQ: COSM) announced the successful completion of testing for its C-Scrub Wash 4%, confirming effective antimicrobial activity under the European standard EN 12791:2016+A1:2017 for surgical hand disinfection. The independent study, conducted by Quality Assurance & Control Systems Ltd. in Greece, validates the product's formulation with 4% Chlorhexidine Digluconate for use in healthcare settings. This achievement is expected to enhance the product's market positioning and create additional commercial opportunities in international healthcare markets.
AI summary, not financial advice
Share: